Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Crystal Amber plots more payouts; Orcadian fundraise

Fri, 01st Jul 2022 21:41

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Crystal Amber Fund Ltd - Guernsey-based investment company - Expects to return further 10 pence per share by mid-August and additional 60p per share by end of September. "If these distributions can be achieved, this would bring total returns in the first nine months of 2022 to 80p a share," Crystal Amber says.

----------

Orcadian Energy PLC - North Sea focused oil and gas development company - Raises GBP1 million through placing of 2.9 million shares at 35 pence each. Cash will go towards licence fees and for general working capital purposes.

----------

Ncondezi Energy Ltd - Mozambique-based power development company - Says restructuring talks in regard to working capital facility term loan with Seritza Ltd "progressing well" and to be finalised "imminently". "Whilst the principle terms are finalised Seritza has confirmed that it will extend the period in which it will not call in the loan to 8 July 2022," Ncondezi says.

----------

East Star Resources PLC - gold and copper exploration company focused on Kazakhstan - Says "multiple mineralised quartz veins" spotted from rock chip samples at Dalny licence on Chu-Ili gold belt in central Kazakhstan. "All quartz vein samples contained gold mineralisation," East Star says.

----------

Bradda Head Lithium Ltd - North America-focused lithium development company - Says results from initial scout drilling programme at Wikieup asset "demonstrate the presence of lithium bearing clays". Chief Executive Charles FitzRoy adds: "Further work is required, but these results are positive and will help in the planning our future programmes there." The project is located halfway between Phoenix and Las Vegas in US.

----------

Artemis Resources Ltd - Perth-based miner with gold, copper and cobalt projects in Australia - Says maiden drill programme planned at Osborne nickel sulphide target underway.

----------

Cornish Metals Inc - Vancouver-based mineral exploration company - Reports assay results from diamond drill holes designed to test Trenares Lode target at United Downs project in Cornwall, UK. Says "multiple zones of mineralisation" intersected at each drill section. Mineralisation is principally "tin - zinc - silver with minor copper".

----------

Hummingbird Resources PLC - gold production, development and exploration focused on West Africa - Says company reserves up "materially" to 4.1 million ounces of gold from 1.1 million ounces reported in November. Resources up 8% to 7.3 million ounces of gold. Updates reserves and resources estimate includes maiden ore reserve at Kinkine deposit, higher-grade ore reserves at the Koekoe deposit and maiden reserves for Dugbe in Liberia.

----------

Open Orphan PLC - London-based pharmaceutical services - Says hVIVO unit is developing the world's first Omicron human challenge model. hVIVO signs deal with Nasdaq-listed Vaxart Inc to develop model to conduct Omicron human challenge study in 2023. Test will test efficacy of Vaxart's oral vaccine candidate, VXA-CoV2-1. "To develop the model, hVIVO will manufacture a new SARS-CoV-2 challenge agent based on the Omicron variant. The Good Manufacturing Practice compliant virus manufacturing activities will commence immediately and are expected to complete by Q4 2022," Open Orphan adds.

----------

Pharma C Investments PLC - New Jersey-based early-stage investor in the medical cannabis industry - Raises GBP200,000 through subscription of 80 million new shares at 0.25 pence each. "The proceeds of the subscription will be used to provide the company with additional working capital," Pharma C says.

----------

Schroder Real Estate Investment Trust Ltd - UK-focused real estate investment trust - Disposes of 26,975 square feet single let industrial asset in Portsmouth for GBP6.5 million. Sales price ops GBP4.9 million March 31 independent valuation. "Further disposals are under consideration, alongside potential acquisitions of adjoining ownerships where these support delivery of the asset business plan," company adds. Since March 31, completes 17 new letting, renewals and review, which will generate additional GBP2.7 million of annual rent and increase contracted rental income by GBP1.0 million per year.

----------

Riverstone Credit Opportunities Income PLC - aims to generate returns by making loans to companies in energy sector - Says realises investment in Roaring Fork Midstream at over 21% internal rate of return. In March of last year, Riverstone had committed USD5.9 million for first lien delayed-draw term loan to sponsor-backed Roaring Fork Midstream. Roaring Fork owns and operates pipeline and storage related infrastructure moving natural gas and oil from the wellhead to market.

----------

Mobile Streams PLC - London-based mobile content provider - Extends contract with International Gaming Systems for additional six months starting July. "The revenue share contract will see the two companies continue to undertake various joint projects in the areas of Esports, gaming and digital merchandise," Mobile Streams adds.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
14 Dec 2020 11:38

Open Orphan upbeat on progress with nasal Covid-19 vaccine

(Sharecast News) - Specialist pharmaceuticals contract research organisation Open Orphan announced on Monday that the first in-human study of the Codagenix intranasal SARS-CoV-2 vaccine candidate for Covid-19 had gained approval from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA).

Read more
24 Nov 2020 16:27

UK EXECUTIVE CHANGE SUMMARY: Ocean Wilson Long-Time Finance Head Exits

UK EXECUTIVE CHANGE SUMMARY: Ocean Wilson Long-Time Finance Head Exits

Read more
19 Nov 2020 21:18

IN BRIEF: Open Orphan To Lead Challenge Agent Development Consortium

IN BRIEF: Open Orphan To Lead Challenge Agent Development Consortium

Read more
5 Nov 2020 16:32

IN BRIEF: Open Orphan Wins GBP2.5 Million Contract For Influenza Study

IN BRIEF: Open Orphan Wins GBP2.5 Million Contract For Influenza Study

Read more
30 Oct 2020 11:30

Open Orphan secures new two-year contract with German client

(Sharecast News) - Pharmaceutical services company Open Orphan announced a new two-year contract with an unnamed tier 1 Germany-based pharmaceutical company on Friday.

Read more
30 Oct 2020 11:07

Open Orphan Inks Two-Year Contract With Tier 1 German Pharma Company

Open Orphan Inks Two-Year Contract With Tier 1 German Pharma Company

Read more
20 Oct 2020 15:59

IN BRIEF: Open Orphan To Develop Covid Study Model For UK Government

IN BRIEF: Open Orphan To Develop Covid Study Model For UK Government

Read more
20 Oct 2020 09:49

Open Orphan to assist UK govt in Covid-19 study

(Sharecast News) - Pharmaceutical services company Open Orphan has signed a contract with the UK Government that will see the firm assist in the development of a Covid-19 human challenge study model to safely speed up the development of an efficacious vaccine.

Read more
16 Oct 2020 15:24

IN BRIEF: Open Orphan In Talks With UK Government Over Corona Study

IN BRIEF: Open Orphan In Talks With UK Government Over Corona Study

Read more
16 Oct 2020 08:57

Open Orphan continues talks over coronavirus challenge study

(Sharecast News) - Open Orphan updated the market on its talks with the UK government and other partners for a coronavirus challenge study in the UK on Friday, confirming that "advanced negotiations" were ongoing.

Read more
30 Sep 2020 18:37

UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise

UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise

Read more
28 Sep 2020 19:34

IN BRIEF: Open Orphan Wins GBP4.3 Million Human Viral Study Contract

IN BRIEF: Open Orphan Wins GBP4.3 Million Human Viral Study Contract

Read more
24 Sep 2020 17:35

UK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail Contract

UK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail Contract

Read more
22 Sep 2020 19:35

IN BRIEF: Open Orphan Lauds Venn's Clinical Study Support Contract Win

IN BRIEF: Open Orphan Lauds Venn's Clinical Study Support Contract Win

Read more
22 Sep 2020 09:43

Open Orphan subsidiary wins 'important' new contract

(Sharecast News) - Pharmaceutical contract research organisation Open Orphan secured an "important" new contract to support an unnamed European client via its French subsidiary, Venn Life Sciences.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.